Skip to main content

Table 2 Perioperative outcomes of patients in both groups

From: Three-port single-intercostal versus multiple-intercostal thoracoscopic lobectomy for the treatment of lung cancer: a propensity-matched analysis

 

Single intercostal (n = 186)

Multi-intercostal (n = 186)

p value

Operative time (min)

135.6 (34.0, 130.7–140.9)

165.4 (32.2, 161.0–170.2)

< 0.001

Blood loss (mL) a

52 (20–350)

100 (40–500)

< 0.001

Conversion

2 (1.1%)

4 (2.2%)

0.681

LN assessment

Total LN removed

25.3 (11.3, 23.7–26.9)

23.8 (9.7, 22.4–25.1)

0.160

Total LN stations removed

6.5 (1.8, 6.2–6.8)

6.7 (1.9, 6.3–6.9)

0.368

Total subcarinal LN removed

6.9 (3.8, 6.4–7.5)

5.2 (3.5, 4.7–5.7)

< 0.001

Chest tube removal (26-Fr) (PODs)

1 (0–18)

3 (2–12)

< 0.001

Length of stay (days)

6.5 (3.1, 6.1–7.0)

6.3 (3.3, 5.8–6.8)

0.478

Major complications

Chylothorax

2 (1.1%)

1 (0.5%)

1.000

Atelectasis

3 (1.6%)

7 (3.2%)

0.200

Pulmonary embolism

1 (0.5%)

0 (0.0%)

1.000

Empyema

1 (0.5%)

2 (1.1%)

1.000

Reoperation

2 (1.1%)

2 (1.1%)

1.000

Total

9 (4.8%)

12 (6.5%)

0.500

Mortally

0 (0.0%)

1 (0.5%)

1.000

  1. Data are presented as median (range) or mean (SD, 95% confidence interval). LN lymph nodes; PODs postoperative days; a: skewed distribution, Mann-Whitney U test applied